Eli Lilly and Company (LLY) - 재무정보
| 연도 | 매출 | 영업이익 | EPS | 부채비율(%) | PER |
|---|---|---|---|---|---|
| FY2020 | $-B | $-B | - | - | - |
| FY2021 | $28.32B | $7.93B | $5.85 | 433.1% | 43.92 |
| FY2022 | $28.54B | $8.65B | $6.57 | 359.3% | 53.95 |
| FY2023 | $34.12B | $10.79B | $5.80 | 489.2% | 104.48 |
| FY2024 | $45.04B | $17.50B | $11.71 | 451.5% | 66.28 |